About Us: Overview

Mission Statement:  Revolutionizing women’s healthcare with innovative solutions 

Conceptus® goals include:

  • Establish the Essure® procedure as the “standard of care” in the permanent birth control market

  • Advance the Company’s leadership role in the office-based delivery of gynecological procedures

  • Provide new ways to deliver innovative solutions to patients and physicians in the field of women’s health

Founded in 1992, Conceptus (NASDAQ: CPTS) is dedicated to the revolutionary design, development, and marketing of innovative solutions in women's health.  Conceptus is also a leader in anticipating and addressing the needs of the U.S. healthcare market.   

The Company’s flagship product, the Essure procedure, was the first-ever successful, non-surgical permanent birth control procedure approved for use in the U.S and Europe, and is the most effective method of permanent birth control available. The Essure procedure is performed using a hysteroscope in less than 10 minutes, typically in a physician’s office, and is less invasive and less expensive than tubal ligation surgery.  Essure has been on the market in the U.S. since 2002 and more than 550,000 Essure procedures have been performed worldwide.  As the pioneer of hysteroscopic sterilization, the Company is committed to establishing Essure as the “standard of care” in permanent birth control. 

In 2005, Conceptus advanced the adoption of minimally-invasive procedures within the clinic setting of the physician’s office.   By demonstrating that the Essure procedure could be done more efficiently in the office instead of the hospital, and obtaining insurance reimbursement for Essure in-office procedures, Conceptus helped revolutionize the way many gynecologists and health systems think about point-of-care delivery.  Today, approximately 70% of Essure procedures are performed in the office, resulting in greater convenience for patients, increased operating efficiency for physicians, and cost savings for payors.  The Company’s leadership in office-based point-of-delivery has paved the way for other minimally-invasive gynecological procedures to be performed in the office.   

The Company seeks to leverage its in-office channel expertise to provide additional products and services for the office setting.